Cite
Pharmacokinetic Targets for Therapeutic Drug Monitoring of Small Molecule Kinase Inhibitors in Pediatric Oncology.
MLA
Janssen, Julie M., et al. “Pharmacokinetic Targets for Therapeutic Drug Monitoring of Small Molecule Kinase Inhibitors in Pediatric Oncology.” Clinical Pharmacology and Therapeutics, vol. 108, no. 3, Sept. 2020, pp. 494–505. EBSCOhost, https://doi.org/10.1002/cpt.1808.
APA
Janssen, J. M., Dorlo, T. P. C., Steeghs, N., Beijnen, J. H., Hanff, L. M., van Eijkelenburg, N. K. A., van der Lugt, J., Zwaan, C. M., & Huitema, A. D. R. (2020). Pharmacokinetic Targets for Therapeutic Drug Monitoring of Small Molecule Kinase Inhibitors in Pediatric Oncology. Clinical Pharmacology and Therapeutics, 108(3), 494–505. https://doi.org/10.1002/cpt.1808
Chicago
Janssen, Julie M, Thomas P C Dorlo, Neeltje Steeghs, Jos H Beijnen, Lidwien M Hanff, Natasha K A van Eijkelenburg, Jasper van der Lugt, C Michel Zwaan, and Alwin D R Huitema. 2020. “Pharmacokinetic Targets for Therapeutic Drug Monitoring of Small Molecule Kinase Inhibitors in Pediatric Oncology.” Clinical Pharmacology and Therapeutics 108 (3): 494–505. doi:10.1002/cpt.1808.